Treatment of Hominis placenta pharmacopuncture for a patient with mild neurocognitive disorder: Case report
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Hominis placenta pharmacopuncture, a treatment that injects Hominis placenta extract into acupoints, has been suggested in the literature and researches that it could be used for cognitive decline. We experienced a case of mild neurocognitive disorder treated with Hominis placenta pharmacopuncture. Hominis placenta pharmacopuncture could be a possible treatment modality producing substantial clinical result in cognitive function which is assessed with Mini-Mental State Examination-Dementia Screening (MMSE-DS), Korean Version of Montreal Cognitive Assessment (MoCA-K), and Korean-Dementia Rating Scale (K-DRS). A 84-yearold man with mild neurocognitive disorder received Hominis placenta pharmacopuncture on GV20, CV12, and bilateral ST36 for a month. The results of neuropsychological examination showed increase in scores after treatment of Hominis placenta pharmacopuncture. Before treatment, they were 15 points for MoCA-K, and 120points for K-DRS (7.6%), but after treatment, they elevated by 21 points for MoCA-K and 137 points for K-DRS (100%). MMSE-DS score was 28 points, unchanged before and after treatment. It did not cause any side-effect. Hominis placenta pharmacopuncture could be a safe option for treating mild neurocognitive disorder.
Abstract
Hominis placenta pharmacopuncture, a treatment that injects Hominis placenta extract into acupoints, has been suggested in the literature and researches that it could be used for cognitive decline. We experienced a case of mild neurocognitive disorder treated with Hominis placenta pharmacopuncture. Hominis placenta pharmacopuncture could be a possible treatment modality producing substantial clinical result in cognitive function which is assessed with Mini-Mental State Examination-Dementia Screening (MMSE-DS), Korean Version of Montreal Cognitive Assessment (MoCA-K), and Korean-Dementia Rating Scale (K-DRS). A 84-yearold man with mild neurocognitive disorder received Hominis placenta pharmacopuncture on GV20, CV12, and bilateral ST36 for a month. The results of neuropsychological examination showed increase in scores after treatment of Hominis placenta pharmacopuncture. Before treatment, they were 15 points for MoCA-K, and 120points for K-DRS (7.6%), but after treatment, they elevated by 21 points for MoCA-K and 137 points for K-DRS (100%). MMSE-DS score was 28 points, unchanged before and after treatment. It did not cause any side-effect. Hominis placenta pharmacopuncture could be a safe option for treating mild neurocognitive disorder.
참고문헌 (31)
- Siegel R, "Cancer statistics", CA Cancer J Clin, 62(1), pp.10~29 (2012)
- 조경민, "Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure", The Korean Journal of Internal Medicine, 30(6), pp.891~898 (2015), 대한내과학회[DOI]
- Wu T, "Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK", mTOR signaling pathway, 2015, pp.9, 6421~6431
- Kapp FG, "5-alpha-reductase type I(SRD5A1)is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis", Cancer Cell Int, 12(1), pp.1~ (2012)
- 표종옥, "Molecules and their functions in autophagy", Experimental and Molecular Medicine, 44(2), pp.73~80 (2012), 생화학분자생물학회
- Mizushima N, "Methods in mammalian autophagy research", Cell, 140(3), pp.313~326 (2010)
- 최경숙, "Autophagy and cancer", Experimental and Molecular Medicine, 44(2), pp.109~120 (2012), 생화학분자생물학회
- Levine B, "Autophagy in the pathogenesis of disease", Cell, 132(1), pp.27~42 (2008)
- Khan M, "Killing cancer with platycodin D through multiple mechanisms", J Cell Mol Med, 20(3), pp.389~402 (2016)
- Hsiao WL, "The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights", Planta Med, 76(11), pp.1118~1131 (2010)
- 안봉전, "내소황련탕(內疎黃連湯) 및 구성약재의 항산화효과 검증과 항암 및 항균효과", 대한본초학회지, 20(4), pp.17~26 (2005), 대한본초학회
- Yi CH, "The Jekyll and Hyde functions of caspases", Dev Cell, 16(1), pp.21~34 (2009)
- Nuñez G, "Caspases : the proteases of the apoptotic pathway", Oncogene, 17(25), pp.3237~3245 (1998)
- Na PY, "Clinacanthus Nutans Hexane Extracts Induce Apoptosis Through a Caspase-Dependent Pathway in Human Cancer Cell Lines", Asian Pac J Cancer Prev, 18(4), pp.917~926 (2017)
- Choi EO, "Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells", Int J Oncol, 49(3), pp.1009~1018 (2016)
- Hua P, "Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells", Biochem Biophys Res Commun, 460(2), pp.136~142 (2015)
- Macek C, "East meets West to balance immunologic yin and yang", JAMA, 251(4), pp.433~435 (1984)
- Shalini S, "Old, new and emerging functions of caspases", Cell Death Differ, 22(4), pp.526~539 (2015)
- Graf RP, "Caspase-8 as a regulator of tumor cell motility", Curr Mol Med, 14(2), pp.246~254 (2014)
- Park C, "Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells", Cancers(Basel), 11(10), pp.1494~ (2019)
- Vijayan V, "Autophagy in the presynaptic compartment in health and disease", J Cell Biol, 216(7), pp.1895~1906 (2017)
- Hooper KM, "Inflammatory Bowel Disease Drugs : A Focus on Autophagy", J Crohns Colitis, 11(1), pp.118~127 (2017)
- Kimmelman AC, "The dynamic nature of autophagy in cancer", Genes Dev, 25(19), pp.1999~2010 (2011)
- Lin SR, "Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy", Int J Mol Sci, 18(7), pp.1412~ (2017)
- Lorin S, "Autophagy regulation and its role in cancer", Semin Cancer Biol, 23(5), pp.361~379 (2013)
- Rosenfeldt MT, "The role of autophagy in tumour development and cancer therapy", Expert Rev Mol Med, 11, pp.e36~ (2009)
- Wang Y, "Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop", Cell Death Dis, 8(6), pp.e2876~ (2017)
- Yu L, "NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKCs inhibitor", Oncotarget, 6(6), pp.3848~3860 (2015)
- Saleh T, "Autophagy is not uniformly cytoprotective : a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer", Biochim Biophys Acta, 1860(10), pp.2130~2136 (2016)
- Chung SJ, "ADIPOQ", adiponectin induces cytotoxic autophagy in breast cancer cells through STK11, Autophagy, pp.2017, 13(8)[DOI]
- Fulda S, "Autophagy in Cancer Therapy", Front Oncol, 7, pp.128~ (2017)